Make no mistake, cannabidiol (CBD) is a primary driver of the marijuana legalization effort in the United States. And the two stocks we're sharing with you today could easily double and triple your money this year.
CBD is the main non-psychoactive component of cannabis. It shows enormous promise for treating a variety of diagnoses. Those include post-traumatic stress disorder, autism, schizophrenia, and more.
CBD is also a good option for children and adults with certain kinds of epilepsy. They treat symptoms without exposing patients to the psychoactive effects of THC.
For many who use CBD oil, the newly available treatment has provided relief when all else failed. About two-thirds of epilepsy patients will respond to the first or second CBD medicine they're given for epilepsy, according to TMC News.
CBD is also rapidly gaining popularity as a general health treatment. People take it for everything - from increasing their energy to alleviating the pain of arthritis.
It's even used as a pet health supplement. And we're starting to see recurring CBD product coverage in The New York Times and The Washington Post, and discussion on national talk shows.
The rapidly growing number of use cases for CBD is promising. And that makes investing in CBD one of the most lucrative things an investor can do today...
The CBD market was worth $813 million by the end of 2019, according Statista.
But the National Institute for Cannabis Investors thinks the market could conservatively grow 146% to $2 billion by the end of 2020.
URGENT: Join Joe Montana and the National Institute for Cannabis Investors at the 2020 American Cannabis Summit. We're limiting space at this once-in-a-lifetime event. Click here now to learn how to claim your FREE spot.
And a recent forecast made by leading cannabis researchers BDS Analytics and Arcview Market Research projects the market could pull in $20 billion by 2024. That would represent 2,360% growth from today.
Today, we're going to show you how the CBD industry can grow to a multibillion-dollar market.
And we'll even give you two of the best CBD stocks to buy to get you started.
One of the most important moments for the CBD industry came at the federal level in 2018.
That's when the new Farm Bill was passed.
The Farm Bill effectively "normalized" CBD in the United States. It made industrial hemp, a major source for CBD, legal on the federal level.
Hemp farmers can now access banking services, crop insurance, and even federal grants for research that were previously unavailable.
For manufacturers and distributors, the Farm Bill made it legal to transport hemp and hemp products (including CBD) across state lines. Retailers can now sell CBD without fear of getting penalized by the U.S. government.
There is a large backlog of companies that have been itching to make or sell products from hemp.
Here are two of the most promising CBD companies on the market today...
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
The number of products featuring CBD seems to grow every day. You can already choose among tinctures (currently the primary form of consumption), gummies, energy shots, nutrition bars, skin moisturizers, infused ingredients like honey, and more.
In a survey of 2,000 U.S. consumers conducted by High Yield Insights in March 2019, 1,500 (75%) reported using a CBD product within the last three months.
Case in point: DSW Inc. (NYSE: DSW) recently announced an agreement to carry products from cannabis healthcare retailer Green Growth Brands Inc. (OTCMKTS: GGBXF).
The National Institute for Cannabis Investors is your go-to source for reliable, up-to-date information about cannabis investing. Click here to automatically subscribe to Cannabis Profits Daily, the Institute's free newsletter, and get industry news and profit opportunities sent right to your inbox.
The announcement follows a successful test phase conducted in the fall of 2018. That's when Green Growth's "Seventh Sense" line of low-priced, high-quality CBD-infused products like muscle balms, body lotions, washes, and foot creams were sold in 10 DSW locations.
During the first 10 weeks of the test, 74% of products on the shelves sold. This blew expectations out of the water.
DSW's partnership with Green Growth is the first nationwide CBD product rollout of its kind. So far, 54,960 units of product have been placed in 96 DSW outlets in the United States.
Green Growth is only trading for $0.30 per share. And it's our No. 2 cannabis stock to buy today because we expect revenue growth to at least double every year over the next two to three years.
GGBXF revenue has set all-time company highs each of the last three quarters.
The company plans to roll out its CBD products to more retailers. So we expect GGBXF stock to conservatively double investors' money in 2020 and jump to at least $0.60 per share.
Charlotte's Web Holdings Inc. (OTCMKTS: CWBHF) is one of the oldest and most trusted CBD companies in the world.
Charlotte's Web was founded in 2011 by six brothers. They named the company after an American girl, Charlotte Figi. Charlotte developed Dravet syndrome (a severe form of epilepsy developed by infants).
By the age of three, Figi was severely disabled - having approximately 300 debilitating seizures per week.
After the Figi parents exhausted all traditional seizure treatment methods, their last hope was high-CBD medical marijuana.
That's when they contacted the Stanley brothers, who gave her some CBD oil drops.
Immediately, Charlotte's parents and physicians noticed improvement in the young girl's health.
Now, Charlotte only has about four mild seizures per month and is able to grow up like most normal children.
Since 2011, Charlotte's Web has grown immensely.
In addition to CBD oils, it now offers CBD capsules, gummies, isolates, creams, balms, and even CBD for dogs.
Most importantly, revenue and profits have grown along the years as well.
From fiscal 2016 to 2018, the company increased its net income 1,823%. Fiscal 2019 hasn't concluded yet, but the company is on pace to beat its 2018 record profits.
But somehow, Wall Street has punished the stock from $23 in August 2019 to $6.41 today.
With CBD market clearly expanding, we think CWBHF stock could easily triple over the next year and get back to the $20 level.
2020 is shaping up to be a landmark year for cannabis markets - and we want you to be able to capitalize on this unprecedented economic phenomenon.
That's why we teamed up with legendary quarterback Joe Montana and cannabis pioneer Danny Brody for the 2020 American Cannabis Summit.
In this extraordinary event, you'll learn the No. 1 trick to spot a winning cannabis IPO...
The biggest investing mistake first-time cannabis investors make...
And the three numbers you absolutely need to check before investing a penny in any cannabis stock.
But remember, space is limited.
Claim your spot now, before it goes live. You're not going to want to miss it.
Follow Money Morning on Facebook and Twitter.